Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Doylestown, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Aprea Therapeutics, Inc. has filed 437 SEC EDGAR filings since 12 Jul 2019

SEC filing history

Showing 351-375 of 437 matching filings.

Per page
25
Current page
15
4

4

Filing date
20 May 2020
Reporting date
09 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 May 2020
Reporting date
18 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39069

FORM 8-K

Filing date
15 May 2020
Reporting date
15 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39069

DEFA14A

Filing date
29 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39069

DEF 14A

Filing date
29 Apr 2020
Reporting date
26 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Apr 2020
Reporting date
13 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39069

FORM 8-K

Filing date
03 Apr 2020
Reporting date
03 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2020
Reporting date
24 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2020
Reporting date
24 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2020
Reporting date
24 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2020
Reporting date
24 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2020
Reporting date
24 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39069

FORM 8-K

Filing date
26 Mar 2020
Reporting date
26 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91159

JANUS HENDERSON GROUP PLC OWNS 8.6% OF APREA

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91159

SC 13G

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91159

SCHEDULE 13G

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91159

SC 13G/A filing

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39069

FORM 8-K

Filing date
13 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39069

FORM 8-K

Filing date
16 Dec 2019
Reporting date
10 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-234765

S-8

Filing date
18 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39069

8-K

Filing date
14 Nov 2019
Reporting date
14 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91159

SC 13G filing

Filing date
12 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .